SHH · 600521.SS
Zhejiang Huahai Pharmaceutical Co., Ltd.
CN¥16.42+CN¥0.52 (+3.27%)
Zhejiang Huahai Pharmaceutical Co., Ltd.’s quoted price sits in the lower half of its reported 52-week range, 15.23% below the high.
Loading market information…
SHH · 600267.SS · CNY
Stock price, dividends, earnings
Quote as of Oct 30, 2026, 05:58 AM UTC. Cached market data; not a live quote.
One-year closing-price history · CNY. Historical prices are not a forecast.
Zhejiang Hisun Pharmaceutical Co., Ltd.’s quoted price sits in the upper half of its reported 52-week range, 13.13% below the high.
52-week range
Go beyond this overview with deeper company research in PortfolioX. Explore more in the app
THE INCOME SIDE
Zhejiang Hisun Pharmaceutical Co., Ltd.’s forward annual dividend is CN¥0.21 per share, paid annual. The forward yield is 1.61% at the quoted price. Future payments can change.
Historical amounts are adjusted for stock splits. Understand ex-dividend and payment dates →
BEHIND THE RESULTS
Zhejiang Hisun Pharmaceutical Co., Ltd.’s next earnings report is currently expected on Mar 26, 2027, with estimated earnings per share of -CN¥0.22. The reporting date and estimates may change.
Upcoming dates and analyst estimates may change. Fiscal quarters follow Zhejiang Hisun Pharmaceutical Co., Ltd.’s reporting calendar.
THE COMPANY BEHIND THE TICKER
Zhejiang Hisun Pharmaceutical Co., Ltd. is a Chinese enterprise engaged in the development, manufacturing, and distribution of a broad spectrum of pharmaceutical products. Its portfolio includes both active pharmaceutical ingredients (APIs) and finished drug formulations. The company's extensive therapeutic focus spans oncology, cardiovascular health, infectious diseases, liver support, orthopedics, parasitic infections, and immunosuppression. Additionally, Hisun Pharmaceutical addresses conditions such as weight management, viral infections, tuberculosis, and offers veterinary pharmaceuticals, among other specialized medical applications. Beyond its product lines, the firm provides product consultation and contract manufacturing/research (CMO/CRO) services. Established in 1956, Zhejiang Hisun Pharmaceutical Co., Ltd. is headquartered in Taizhou, China.
Latest available per-share figures in CNY. The payout ratio compares dividends with earnings.
About this data · PortfolioX market data, also available in the mobile app. Prices are displayed in the listing currency; dividend amounts use the currency shown in that section. Data availability and update times vary.
Page generated Oct 30, 2026, 06:13 AM UTC. Quotes retain their own timestamp above. Missing values appear as a dash. This page is for information only, not personalized investment advice.
Completed calendar years and any current-year payments shown separately. Current-year totals are incomplete until all payments are made.
See annual income at the current dividend rate.
Assumes the annual dividend stays unchanged. Payments follow the company’s schedule. Excludes taxes, fees and currency changes.
| CN¥2.67B |
| Q3 2025 | Jun 30, 2025 | CN¥0.09-35.61% vs estimate | CN¥2.62B |
|---|
| Q1 2025 | Apr 16, 2025 | CN¥0.17+88.89% vs estimate | CN¥2.63B |
|---|
| Q4 2024 | Mar 28, 2025 | CN¥0.08+366.67% vs estimate | CN¥1.91B |
|---|
HOW THE BUSINESS IS PERFORMING
Statement amounts use the company’s reporting currency and are not converted to the stock’s listing currency. K = thousand, M = million, B = billion, T = trillion. Cash-flow figures are matched by fiscal year; missing figures appear as a dash.
PUT THE NUMBERS IN CONTEXT
Current metrics alongside available historical medians. A lower multiple or higher margin alone does not establish whether a stock is a good investment.
KEEP COMPARING
CN¥16.42+CN¥0.52 (+3.27%)
Zhejiang Huahai Pharmaceutical Co., Ltd.’s quoted price sits in the lower half of its reported 52-week range, 15.23% below the high.
CN¥19.48-CN¥0.02 (-0.1%)
Apeloa Pharmaceutical Co.,Ltd’s quoted price sits in the lower half of its reported 52-week range, 31.65% below the high.
CN¥15.68+CN¥0.63 (+4.19%)
Zhejiang Jiuzhou Pharmaceutical Co., Ltd’s quoted price sits in the lower half of its reported 52-week range, 29.53% below the high.
CN¥5.63-CN¥0.17 (-2.93%)
Zhejiang Hisoar Pharmaceutical Co., Ltd.’s quoted price sits in the lower half of its reported 52-week range, 38.06% below the high.
CN¥8.92+CN¥0.06 (+0.68%)
Zhejiang Xianju Pharmaceutical Co.,Ltd.’s quoted price sits in the lower half of its reported 52-week range, 11.24% below the high.
CN¥19.95-CN¥0.10 (-0.5%)
Zhejiang Tianyu Pharmaceutical Co., Ltd.’s quoted price sits in the lower half of its reported 52-week range, 28.24% below the high.
CN¥7.35+CN¥0.14 (+1.94%)
Zhejiang Ausun Pharmaceutical Co., Ltd.’s quoted price sits in the lower half of its reported 52-week range, 32.01% below the high.
CN¥6.92+CN¥0.14 (+2.06%)
Jinghua Pharmaceutical Group Co., Ltd.’s quoted price sits in the lower half of its reported 52-week range, 27.84% below the high.
